TransMedics Group, Inc. (TMDX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $605.49M | +37.1% |
| 2024 | $441.54M | +82.7% |
| 2023 | $241.62M | +158.5% |
| 2022 | $93.46M | +208.8% |
| 2021 | $30.26M | +18.0% |
| 2020 | $25.64M | +8.6% |
| 2019 | $23.60M | +81.3% |
| 2018 | $13.02M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $605.49M | +37.1% |
| 2024 | $441.54M | +82.7% |
| 2023 | $241.62M | +158.5% |
| 2022 | $93.46M | +208.8% |
| 2021 | $30.26M | +18.0% |
| 2020 | $25.64M | +8.6% |
| 2019 | $23.60M | +81.3% |
| 2018 | $13.02M | — |